Bioleaders Corporation announced that it will issue series 8 unregistered coupon nonguaranteed private convertible bonds for gross proceeds of KRW 5,000,000,000 and series 9 bearer type unguaranteed private equity exchange bonds for gross proceeds of KRW 8,000,000,000; for an aggregate gross proceeds of KRW 13,000,000,000 on November 29, 2021. The transaction includes participation for series 8 bonds from new investors, SP Asset Management Co., Ltd. for KRW 3,000,000,000, Blash Asset Management Co., Ltd for KRW 1,300,000,000 and Tiger Asset Management Discretionary Investment Co., Ltd. for KRW 700,000,000. The series 8 bonds bear nil coupon and 0% yield to maturity. The series 8 bonds will mature on November 30, 2026. The bonds will be issued at par. The series 8 bonds are fully convertible into 599,232 shares representing 2.09% stake at a fixed conversion price of KRW 8,344 each starting from November 30, 2022 till October 30, 2026. The series 8 bonds are redeemable. The series 9 bonds are exchangeable. The payment date for series 8 bonds and series 9 bonds are November 30, 2021 and December 1, 2021 respectively. The transaction has been approved by the board of directors of the company.